New strategy shows promise against cancer drug resistance
A protein that helps cancer cells control oxidative stress may explain why some blood cancers eventually stop responding to BTK ...
A protein that helps cancer cells control oxidative stress may explain why some blood cancers eventually stop responding to BTK ...
UCLA researchers have identified a way to make antibody-drug conjugates more powerful against metastatic castration-resistant prostate cancer, an advanced form ...
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
A new study in Nature Communications reveals how cancer cells can use the body’s own defenses against them. The work, ...
A groundbreaking study published in Nature Communications unveils a novel approach to treating brain metastases with unprecedented precision and efficacy. ...
In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic ...
In a groundbreaking advancement poised to reshape the landscape of cancer diagnosis and treatment, researchers from a multidisciplinary team have ...
In a groundbreaking advancement in the field of oncology drug discovery, researchers have harnessed the power of deep learning to ...
In a groundbreaking systematic review published in the Journal of Translational Medicine, researchers led by Zhang and colleagues explore the ...
In a groundbreaking study published in Scientific Reports, researchers have unveiled a novel zinc complex that could revolutionize cancer treatment ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine